The color you see in total darkness has a name, and it's not 'black'
When you close your eyes or sit in pitch darkness, what do you see? Most would instinctively say 'black,' but your brain is telling you something else. That deep, indescribable hue isn't true black—it's something far more unique. It's called
Eigengrau
, a German word meaning 'intrinsic gray' or 'brain gray,' and it's one of the most curious
visual phenomena
in the human experience.
Eigengrau isn't born from light, shadow, or pigment. It's an illusion—your brain's way of coloring the silence when all external light disappears. Even in absolute darkness, your eyes and brain remain active. Neurons in your retina keep firing at a low rate, producing faint patterns and signals, which your brain interprets as a uniform, dark gray. In this way, Eigengrau is not what we see with our eyes, but what our brains
think
we're seeing.
The Color That Exists Only in Your Mind
Unlike any other color, Eigengrau isn't found on a paint chip or in a digital hex code. You can't replicate it because it's not made by mixing hues—it's a visual experience created entirely within your mind. In fact, Eigengrau is unique to each person, shaped by their individual brain chemistry,
retinal activity
, and perception. Some may experience a darker version, others a touch lighter, occasionally dotted with tiny moving lights or faint static. This "
visual noise
" has fascinated scientists for centuries.
Since the 19th century, researchers have studied how even in complete darkness, the human retina produces random electrical signals that the brain processes as vision. It's a kind of
self-made twilight
, a liminal space between seeing and not seeing. These spontaneous retinal events—largely caused by the thermal motion of molecules like rhodopsin—create a persistent illusion of faint grayness. In a poetic way, Eigengrau is our mind's refusal to accept total darkness.
Astronauts, Stars, and the Science of Not-Seeing
What's even more fascinating is how Eigengrau behaves in contrast. In a starry sky, the darkness around the stars appears deeper than Eigengrau because our eyes are wired to notice
contrast
more than absolute brightness. That's why the night sky can feel darker than the color you see when you close your eyes.
You Might Also Like:
Purple is a lie: Why your brain invented a colour that does not exist in nature? Scientists reveal
Astronauts, in the vast blackness of space, report seeing Eigengrau more vividly than we do on Earth—proof of how the brain continues to fill visual voids, even in the most light-deprived environments. It's not just a color but a survival tool, an evolutionary quirk that keeps our visual system humming even when there's nothing to see.
iStock
In a starry sky, the darkness around the stars appears deeper than Eigengrau because our eyes are wired to notice contrast more than absolute brightness. (Representational image: iStock)
A Shared Phenomenon, a Personal Experience
Though nearly universal, Eigengrau is a deeply personal experience. Each brain interprets its own version of darkness, and no two people see it exactly the same. It's a quiet, constant reminder that our minds are always active—interpreting, imagining, and even inventing what isn't there. Eigengrau reminds us that perception isn't just about what enters our eyes—it's about how our brains make sense of it.
So next time you find yourself alone in the dark, remember: you're not looking at nothing. You're witnessing one of the most mysterious and intimate shades in the universe. A color that belongs to no one but you, yet is seen by everyone. A color that doesn't exist in the world—but lives entirely in your mind.
You Might Also Like:
What is your favourite colour? Does it really matter, psychologist reveals
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
42 minutes ago
- Time of India
Why did Albert Einstein drop out of school at the age of 15? The powerful lesson every student can learn from his exit
Why did Albert Einstein drop out of school at the age of 15? Albert Einstein did not merely drift away from school; he broke from it with the quiet force of a mind unwilling to be shackled. At fifteen, he walked out of Munich's Luitpold Gymnasium–a prestigious secondary school—not in rebellion, but in refusal, a refusal to conform to the rigid, authoritarian machinery of an education system that prized obedience over understanding. It was, in hindsight, the first bold rupture in a life that would come to be defined by its elegant resistance to convention. The boy who would one day upend the known universe with his theory of relativity began by rejecting a far smaller—but no less suffocating—universe, the narrow classroom in which curiosity was subordinate to command. The School That Stifled Genius Luitpold Gymnasium (now Albert-Einstein-Gymnasium) was no ordinary school. It was a bastion of classical Prussian-style education — heavily focussed on rote memorization, strict discipline, and unbending obedience to authority. For the young Einstein, this was not just uninspiring — it was suffocating. Einstein's sister, Maja, later wrote about his inner turmoil. 'The military tone of the school, the systematic training in the worship of authority that was supposed to accustom pupils at an early age to military discipline, was also particularly unpleasant for the boy. He contemplated with dread that not-too-distant moment when he will have to don a soldier's uniform in order to fulfill his military obligations. ' The dread wasn't unfounded. Under German citizenship laws at the time, a male citizen was not allowed to emigrate after age 16 unless he fulfilled his military duty. Failing to do so meant being labeled a deserter. The Smile That Infuriated Authority Einstein's resistance to this environment went beyond quiet discontent — it became a visible defiance. In Subtle is the Lord: The Science and Life of Albert Einstein , author Abraham Pais recounted a striking story from Einstein's classroom days. 'At the Gymnasium a teacher once said to him that he, the teacher, would be much happier if the boy were not in his class. Einstein replied that he had done nothing wrong. The teacher answered, 'Yes, that is true. But you sit there in the back row and smile, and that violates the feeling of respect that a teacher needs from his class,'' he wrote. This wasn't just a matter of behaviour; it was a cultural collision. Einstein's quiet smile, a subtle protest against blind authority, was seen as insubordination in a system where questioning was equated with rebellion. The same teacher had later declared, infamously, that Einstein 'would never get anywhere in life.' A Strategic Escape Einstein, unhappy and increasingly anxious about being conscripted into the military, devised an unusual exit strategy. With help from a sympathetic doctor, he obtained a certificate stating he was suffering from 'mental exhaustion'. Using this as grounds for withdrawal, he left the Gymnasium without a diploma — and without informing most of his teachers. He fled to Italy to rejoin his family, who had moved to Milan months earlier after the collapse of his father's electrical business. He was now, technically, a dropout — but far from defeated. Einstein used his time in Italy to continue self-study, especially in advanced mathematics and physics. Within a year, he applied to the Swiss Federal Polytechnic in Zurich. Although he initially failed the general section of the entrance exam, his exceptional performance in math and physics earned him admission — after completing a year of preparatory schooling in Aarau, Switzerland. A Dropout From Obedience, Not School Einstein's withdrawal from the Luitpold Gymnasium has often been portrayed as an early stumble—a boy disillusioned, a student who could not adjust. But to read it that way is to miss the deeper current shaping his life. This was not retreat; it was realignment. In choosing to walk away from the regimented corridors of a system designed to mold rather than awaken, Einstein took his first deliberate step toward the intellectual independence that would define him. The very atmosphere that sought to contain him—the rote drills, the deference to authority, the absence of curiosity—became the crucible in which his lifelong resistance to conformity was forged. He did not abandon learning. He simply refused to accept that learning must come with submission. In that moment, quietly and without ceremony, Einstein affirmed a principle that would echo through his science and his life: that truth is not handed down by authority—it is discovered by questioning it. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Economic Times
a day ago
- Economic Times
Is this little-known, gluten-free seed the ultimate superfood for lowering cholesterol and losing weight?
iStock Amaranth, an ancient pseudocereal rich in calcium, iron, protein, and fiber, is gaining recognition for its impressive health benefits. Studies show it supports bone strength, lowers bad cholesterol, aids digestion, fights inflammation, and helps regulate blood sugar. (Representational Image: iStock) In the quest for better health, one humble seed is attracting growing attention from scientists and nutritionists alike. Amaranth, a pseudocereal revered by ancient Aztecs, is fast emerging as a powerhouse ingredient capable of strengthening bones, cutting cholesterol, and aiding weight management. But what makes this ancient grain so remarkable? According to a report from The Mirror , amaranth isn't your typical cereal grain. Classified as a pseudocereal, it is a non-grass plant consumed much like true cereals but uniquely gluten-free. Dr. Julieta M. Lopez-Martinez highlights that amaranth is rich in calcium and iron, essential minerals that support bone strength and may even help prevent cellular changes linked to tumor development. A study from Vienna's BOKU-University further praises amaranth as 'one of the most promising food plant genera,' thanks to its high-quality protein, unsaturated oils, fiber, and essential minerals. — Farmsent_io (@Farmsent_io) Dr. Josh Axe, a clinical nutritionist, explains that amaranth encompasses over 60 species and was once a staple food for the Aztecs. From its leaves used medicinally to its grain serving as a fiber-rich protein source and oil applied for skin health, amaranth offers diverse benefits. Its complete protein content carries anti-inflammatory and antioxidant properties, making it an ideal addition to combat heart disease, digestive issues, and chronic inflammation. Calcium is critical for bone repair and strength, and amaranth provides a significant dose. Dr. Axe emphasizes that adequate calcium intake can reduce the risk of fractures and osteoporosis, a condition marked by weakened bones. Regular consumption of amaranth supports skeletal health, helping maintain mobility and physical activity, especially important as we age. Amaranth's fiber content plays a key role in managing cholesterol and improving digestion. Research published in the International Journal for Vitamin and Nutrition Research found amaranth could lower harmful LDL cholesterol by up to 50%. Its mix of insoluble and soluble fibers traps fats and toxins in the digestive tract, facilitating their elimination and promoting gut health. Scientists at Purdue University confirm that amaranth contains a higher proportion of soluble fiber than wheat or maize, enhancing its digestive benefits. One cup of amaranth delivers more than the recommended daily manganese, a mineral vital in regulating blood sugar through gluconeogenesis—the process of converting protein into glucose. Studies indicate that manganese deficiency may impair glucose balance and kidney function, highlighting amaranth's role in diabetes management. Its rich protein and fiber content also promote satiety, reducing overeating and supporting weight loss. By keeping digestion regular and inflammation at bay, amaranth helps maintain a healthy metabolism and physical activity levels, both crucial for sustainable weight control. From ancient times to today's nutritional science, amaranth has proven itself a versatile, nutrient-dense food with far-reaching health benefits. Whether you incorporate it as flour, grain, leaf, or oil, this seed offers a natural, powerful boost to bone health, cholesterol management, diabetes control, and weight loss efforts. With science backing its myriad benefits, amaranth might just be the secret weapon your diet needs for a stronger, healthier body.
Time of India
2 days ago
- Time of India
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could take on rival Merck & Co's best-selling drug Keytruda. The deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on experimental cancer treatments and show that its success as Pfizer 's COVID-19 vaccine partner was not a one-off achievement. It also underscores a push across the pharma sector to master a new dual mechanism of action in oncology that activates the immune system - similar to an established drug class including Merck & Co's Keytruda - but which also cuts a tumour's blood supply. BioNTech's German-listed shares surged 16.7% by 1236 GMT to a six-week high. The two companies said in separate statements that the U.S. group will co-develop and co-commercialize BioNTech's drug, BNT327, for multiple solid tumour types. Live Events BioNTech's CEO and co-founder Ugur Sahin said the collaboration will serve "to accelerate and broadly expand BNT327's development to fully realize its potential." The companies said in presentation slides that Bristol Myers was bringing global networks in clinical development and manufacturing to the partnership, among other benefits. BioNTech said in a statement that the partners were seeking to set a new standard of care in the cancer market segment, now dominated by so-called checkpoint inhibitors including Keytruda with $29.5 billion in 2024 sales. Western drugmakers have struck a host of deals to win access to the new drug technology, known as PD-1/VEGF bispecific antibodies, which was pioneered in China. Pfizer last month partnered with China's 3SBio , paying $1.25 billion upfront and up to another $4.8 billion depending on developmental achievements. Merck & Co, whose Keytruda business is under threat from the sector's development push, in November last year licensed an early-stage cancer drug from China-based LaNova Medicines for up to $3.3 billion. "We are now starting to see an industry vote of confidence in the differentiation of this novel mechanism," BMO Capital Markets analysts said in a note. They welcomed BioNTech "partnering with a big pharma name to help manage a broad development plan and potential commercialization". Shares in Instil Bio, which is working with China's ImmuneOnco on a similar compound, soared 24% in U.S. trade on Monday. Summit Therapeutics and China's Akeso have formed another partnership in the development race with a drug candidate called ivonescimab. BioNTech took full ownership of BNT327 through the acquisition of China's Biotheus earlier this year for $800 million upfront and up to $150 million contingent on development achievements. It previously held certain rights in the drug under a 2023 collaboration deal. In addition to an initial payment of $1.5 billion, Bristol plans to pay BioNTech $2 billion in non-contingent anniversary payments through 2028. BioNTech may also earn up to $7.6 billion in development, regulatory and commercial milestones, Bristol said. The companies will share global profits and losses from the drug equally, and joint development and manufacturing costs will also be shared on a 50/50 basis, with some exceptions. BNT327 is being tested as a first-line treatment in extensive stage small cell lung cancer and non-small cell lung cancer. More than 1,000 patients have been treated with the drug to date. Economic Times WhatsApp channel )
